|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CCNT2-ZER1 (FusionGDB2 ID:HG905TG10444) |
Fusion Gene Summary for CCNT2-ZER1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CCNT2-ZER1 | Fusion gene ID: hg905tg10444 | Hgene | Tgene | Gene symbol | CCNT2 | ZER1 | Gene ID | 905 | 10444 |
Gene name | cyclin T2 | zyg-11 related cell cycle regulator | |
Synonyms | CYCT2 | C9orf60|ZYG|ZYG11BL | |
Cytomap | ('CCNT2')('ZER1') 2q21.3 | 9q34.11 | |
Type of gene | protein-coding | protein-coding | |
Description | cyclin-T2SDS-stable vimentin-bound DNA fragment HEF42VIM22cyclin T2acyclin T2bsubunit of positive elongation transcription factor b | protein zer-1 homologZYG homologzer-1 homologzyg-11 homolog B-like proteinzyg11b-like protein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | O60583 | . | |
Ensembl transtripts involved in fusion gene | ENST00000264157, ENST00000295238, ENST00000537343, | ||
Fusion gene scores | * DoF score | 5 X 4 X 6=120 | 8 X 8 X 5=320 |
# samples | 7 | 10 | |
** MAII score | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/320*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CCNT2 [Title/Abstract] AND ZER1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CCNT2(135677461)-ZER1(131505024), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CCNT2-ZER1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CCNT2-ZER1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CCNT2 | GO:0019085 | early viral transcription | 21509660 |
Hgene | CCNT2 | GO:0019086 | late viral transcription | 21509660 |
Hgene | CCNT2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 15563843 |
Fusion gene breakpoints across CCNT2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ZER1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8295-01A | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
Top |
Fusion Gene ORF analysis for CCNT2-ZER1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000264157 | ENST00000494461 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
5CDS-intron | ENST00000295238 | ENST00000494461 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
5UTR-3CDS | ENST00000537343 | ENST00000291900 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
5UTR-intron | ENST00000537343 | ENST00000494461 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
In-frame | ENST00000264157 | ENST00000291900 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
In-frame | ENST00000295238 | ENST00000291900 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000295238 | CCNT2 | chr2 | 135677461 | + | ENST00000291900 | ZER1 | chr9 | 131505024 | - | 2763 | 270 | 30 | 1211 | 393 |
ENST00000264157 | CCNT2 | chr2 | 135677461 | + | ENST00000291900 | ZER1 | chr9 | 131505024 | - | 2763 | 270 | 30 | 1211 | 393 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000295238 | ENST00000291900 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - | 0.011856002 | 0.988144 |
ENST00000264157 | ENST00000291900 | CCNT2 | chr2 | 135677461 | + | ZER1 | chr9 | 131505024 | - | 0.011856002 | 0.988144 |
Top |
Fusion Genomic Features for CCNT2-ZER1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for CCNT2-ZER1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:135677461/chr9:131505024) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CCNT2 | . |
FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II) (PubMed:9499409, PubMed:15563843). The activity of this complex is regulated by binding with 7SK snRNA (PubMed:11713533). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (By similarity). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (PubMed:16331689). Involved in early embryo development (By similarity). {ECO:0000250|UniProtKB:Q7TQK0, ECO:0000269|PubMed:11713533, ECO:0000269|PubMed:15563843, ECO:0000269|PubMed:16331689, ECO:0000269|PubMed:9499409}.; FUNCTION: (Microbial infection) Promotes transcriptional activation of early and late herpes simplex virus 1/HHV-1 promoters. {ECO:0000269|PubMed:21509660}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 511_556 | 453 | 767.0 | Repeat | Note=ARM 2 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 558_600 | 453 | 767.0 | Repeat | Note=ARM 3 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 602_643 | 453 | 767.0 | Repeat | Note=ARM 4 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 714_756 | 453 | 767.0 | Repeat | Note=ARM 5 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000264157 | + | 2 | 9 | 530_660 | 80 | 731.0 | Compositional bias | Ser-rich |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000264157 | + | 2 | 9 | 665_671 | 80 | 731.0 | Compositional bias | Note=Poly-Pro |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000295238 | + | 2 | 10 | 530_660 | 80 | 664.0 | Compositional bias | Ser-rich |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000295238 | + | 2 | 10 | 665_671 | 80 | 664.0 | Compositional bias | Note=Poly-Pro |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000264157 | + | 2 | 9 | 12_147 | 80 | 731.0 | Domain | Cyclin N-terminal |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000295238 | + | 2 | 10 | 12_147 | 80 | 664.0 | Domain | Cyclin N-terminal |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 226_245 | 453 | 767.0 | Repeat | Note=LRR 1 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 246_268 | 453 | 767.0 | Repeat | Note=LRR 2 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 278_302 | 453 | 767.0 | Repeat | Note=LRR 3 | |
Tgene | ZER1 | chr2:135677461 | chr9:131505024 | ENST00000291900 | 7 | 16 | 427_467 | 453 | 767.0 | Repeat | Note=ARM 1 |
Top |
Fusion Gene Sequence for CCNT2-ZER1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>14203_14203_1_CCNT2-ZER1_CCNT2_chr2_135677461_ENST00000264157_ZER1_chr9_131505024_ENST00000291900_length(transcript)=2763nt_BP=270nt AATGAAGGAGCGGGCGGAGGAGGAAGTGTCATGGCGTCGGGCCGTGGAGCTTCTTCTCGCTGGTTCTTTACTCGGGAACAGCTGGAGAAC ACGCCGAGCCGCCGCTGCGGAGTGGAGGCGGATAAAGAGCTCTCGTGCCGCCAGCAGGCGGCCAACCTCATCCAGGAGATGGGACAGCGT CTCAATGTCTCTCAGCTTACAATAAACACTGCGATTGTTTATATGCACAGGTTTTATATGCACCATTCTTTCACCAAATTCAACAAAAAT GTGCAGCGGAACTGCTGCCTGACGCTCTGCAACTTCAGCATCCCCGAGGAGCTGGAATTCCAGTACCGCCGGGTCAACGAGCTCCTGCTC AGCATCCTCAACCCCACGCGGCAGGACGAGTCTATCCAGCGGATCGCCGTGCACCTGTGCAATGCCCTGGTCTGCCAGGTAGACAACGAC CACAAGGAGGCCGTGGGCAAGATGGGCTTTGTCGTGACCATGCTGAAGCTGATTCAGAAGAAGCTGCTGGACAAGACATGTGACCAGGTC ATGGAGTTCTCCTGGAGTGCCCTGTGGAACATCACAGATGAAACTCCTGACAACTGCGAGATGTTCCTCAATTTCAACGGCATGAAGCTC TTCCTGGACTGCCTGAAGGAATTCCCAGAGAAGCAGGAACTGCATAGGAATATGCTAGGACTTTTGGGGAATGTGGCAGAAGTGAAGGAG CTGAGGCCTCAACTAATGACTTCCCAGTTCATCAGCGTCTTCAGCAACCTGTTGGAGAGCAAGGCCGATGGGATCGAGGTTTCCTACAAT GCCTGCGGCGTCCTCTCCCACATCATGTTTGATGGACCCGAGGCCTGGGGCGTCTGTGAGCCCCAGCGTGAGGAGGTGGAGGAACGCATG TGGGCTGCCATCCAGAGCTGGGACATAAACTCTCGGAGAAACATCAATTACAGGTCATTTGAACCAATTCTCCGCCTCCTTCCCCAGGGA ATCTCTCCTGTCAGCCAGCACTGGGCAACCTGGGCCCTGTATAACCTCGTGTCTGTCTACCCGGACAAGTACTGCCCTCTGCTGATCAAA GAAGGGGGGATGCCCCTTCTGAGGGACATAATTAAGATGGCGACCGCACGGCAGGAGACCAAGGAAATGGCCCGCAAGGTGATTGAGCAC TGCAGTAACTTTAAAGAGGAGAACATGGACACGTCTAGATAGAGGCCTCCGTCCCCATGGCCGCCACCGCTCTGGACCACAGGCGGGGAG GAAGCATGCTCAAGCAGCCCAGCGGGCGGGCCCCTTCCGAGGGAGCCTCCCACGGAGTGAAGAGACATGGGGGACTTTTGCACAACCGAC GCTTTTCCTTAATGTTAGTGAGATATATATATATTATATATATATATTTTTTTTTTGGTTAGGAAGTGTGAAGTTTTGTGTGTATGATTT CTGTGCAAAAACAAAAGCAACACTCCTGAGTCCTTGCAGCTTCCTTGGCCATTCTCAAACCCACTCAGCCTTCATCGCTGACACACACAC TCCTACCCCAACCAGACTAAATGCCTATAACGCTGTGAGTGTCCAGTCCTTGTCCAGGAAACTCAGATCCCGGCCTGGCTTCCTTTCATG AGAGGAGCAGGCCTTGGACAGCGTATCGAGCATCCTGACCCACTGCCCCTGCCTGAGAACGCCATCTCGGCTCCCGGGCACAGCTGATGG GGTTTGGGGATTAGAACTTACCCCACTGGGTCTCCCAAAAGCCTTGGTGCTCCCGGCTGTGGGCCATCTGGGGCAGGAAAGTGAGCCATT CCTAGGCTGAGGTCCAGGCAGCCCTGCCCCTGAAGACCCTCTAGGAGCAGGGCACCCAGTGGCCCTGCTGCTGTCCAGCCAGGCCTGCCT GAGGCCACGCTGCTATGGAGGCTGCCTCCTAGTCTCCCACCAGGTCCCAGGCTGTGGAAAGCCCCAGCCCAGGGATGGTCAGAACTCAGG GGCAGATTCCACTGCCCCTTCTGCCAAACACATCCAGAACCTGCCCTCAGCCCTGGAAGCTAGCATCTTCTGGGGCCAGGGGCTTGCTTC CTCGCTCCATAGCCCTCAACTGCCCAGGCGCTCCCACCAGCAGAACTGAGCCTGCCTCCTCCTCCCAGCCTGCCCCGCTGCCCAGAGGAC CCCACGCCTCTCAGAGGCAGAGGTCCCATGACAGCCTTTGACCCACAACGGCCACACAGCCGCCTCCAGACCAGCACTCGGACTGCCCTG CAGTGGCCGCTTGGGCCTCCCTGGCGGTCCCGCCCTGCCCTAGGCTTTACCTTGGAAGCCTGAGAGGCGCCGGCTCTCTTGCTCCTCCAT CGATGGACACTGCATTGCTTCTCATCGGACACTTGTGGAGCGCAGGGGCCTGGGGAGCAGCGCTAACCCTGGAGGCAGCCTTTGGGTGAT GGCTTTTTCTTCCCTTTTCCTCCCGCGGGCCTGTTTTCAGGTGTTCCTAGCATTTCTGCCTCCAGGCAGGACGGCAGGGGTGAGCAGCTT TGGGAGAGACACCTGGCCTTTTTCTCCTGGAGCCTCTCCCTCCCGGCCCTGGGAAGTGGGCGCAGCCCTGTGTTCCCCCAGCTTGGCAGA TGGGCTGCATGCGGCGCTCCCTTCCTTCCCACGCTCAGCGGCCCCGGCCAGACCCTGGCAGACTTCACACCTCATTGCTTTACCCCCTGG >14203_14203_1_CCNT2-ZER1_CCNT2_chr2_135677461_ENST00000264157_ZER1_chr9_131505024_ENST00000291900_length(amino acids)=393AA_BP=80 MASGRGASSRWFFTREQLENTPSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNVQRNCCLTLC NFSIPEELEFQYRRVNELLLSILNPTRQDESIQRIAVHLCNALVCQVDNDHKEAVGKMGFVVTMLKLIQKKLLDKTCDQVMEFSWSALWN ITDETPDNCEMFLNFNGMKLFLDCLKEFPEKQELHRNMLGLLGNVAEVKELRPQLMTSQFISVFSNLLESKADGIEVSYNACGVLSHIMF DGPEAWGVCEPQREEVEERMWAAIQSWDINSRRNINYRSFEPILRLLPQGISPVSQHWATWALYNLVSVYPDKYCPLLIKEGGMPLLRDI -------------------------------------------------------------- >14203_14203_2_CCNT2-ZER1_CCNT2_chr2_135677461_ENST00000295238_ZER1_chr9_131505024_ENST00000291900_length(transcript)=2763nt_BP=270nt AATGAAGGAGCGGGCGGAGGAGGAAGTGTCATGGCGTCGGGCCGTGGAGCTTCTTCTCGCTGGTTCTTTACTCGGGAACAGCTGGAGAAC ACGCCGAGCCGCCGCTGCGGAGTGGAGGCGGATAAAGAGCTCTCGTGCCGCCAGCAGGCGGCCAACCTCATCCAGGAGATGGGACAGCGT CTCAATGTCTCTCAGCTTACAATAAACACTGCGATTGTTTATATGCACAGGTTTTATATGCACCATTCTTTCACCAAATTCAACAAAAAT GTGCAGCGGAACTGCTGCCTGACGCTCTGCAACTTCAGCATCCCCGAGGAGCTGGAATTCCAGTACCGCCGGGTCAACGAGCTCCTGCTC AGCATCCTCAACCCCACGCGGCAGGACGAGTCTATCCAGCGGATCGCCGTGCACCTGTGCAATGCCCTGGTCTGCCAGGTAGACAACGAC CACAAGGAGGCCGTGGGCAAGATGGGCTTTGTCGTGACCATGCTGAAGCTGATTCAGAAGAAGCTGCTGGACAAGACATGTGACCAGGTC ATGGAGTTCTCCTGGAGTGCCCTGTGGAACATCACAGATGAAACTCCTGACAACTGCGAGATGTTCCTCAATTTCAACGGCATGAAGCTC TTCCTGGACTGCCTGAAGGAATTCCCAGAGAAGCAGGAACTGCATAGGAATATGCTAGGACTTTTGGGGAATGTGGCAGAAGTGAAGGAG CTGAGGCCTCAACTAATGACTTCCCAGTTCATCAGCGTCTTCAGCAACCTGTTGGAGAGCAAGGCCGATGGGATCGAGGTTTCCTACAAT GCCTGCGGCGTCCTCTCCCACATCATGTTTGATGGACCCGAGGCCTGGGGCGTCTGTGAGCCCCAGCGTGAGGAGGTGGAGGAACGCATG TGGGCTGCCATCCAGAGCTGGGACATAAACTCTCGGAGAAACATCAATTACAGGTCATTTGAACCAATTCTCCGCCTCCTTCCCCAGGGA ATCTCTCCTGTCAGCCAGCACTGGGCAACCTGGGCCCTGTATAACCTCGTGTCTGTCTACCCGGACAAGTACTGCCCTCTGCTGATCAAA GAAGGGGGGATGCCCCTTCTGAGGGACATAATTAAGATGGCGACCGCACGGCAGGAGACCAAGGAAATGGCCCGCAAGGTGATTGAGCAC TGCAGTAACTTTAAAGAGGAGAACATGGACACGTCTAGATAGAGGCCTCCGTCCCCATGGCCGCCACCGCTCTGGACCACAGGCGGGGAG GAAGCATGCTCAAGCAGCCCAGCGGGCGGGCCCCTTCCGAGGGAGCCTCCCACGGAGTGAAGAGACATGGGGGACTTTTGCACAACCGAC GCTTTTCCTTAATGTTAGTGAGATATATATATATTATATATATATATTTTTTTTTTGGTTAGGAAGTGTGAAGTTTTGTGTGTATGATTT CTGTGCAAAAACAAAAGCAACACTCCTGAGTCCTTGCAGCTTCCTTGGCCATTCTCAAACCCACTCAGCCTTCATCGCTGACACACACAC TCCTACCCCAACCAGACTAAATGCCTATAACGCTGTGAGTGTCCAGTCCTTGTCCAGGAAACTCAGATCCCGGCCTGGCTTCCTTTCATG AGAGGAGCAGGCCTTGGACAGCGTATCGAGCATCCTGACCCACTGCCCCTGCCTGAGAACGCCATCTCGGCTCCCGGGCACAGCTGATGG GGTTTGGGGATTAGAACTTACCCCACTGGGTCTCCCAAAAGCCTTGGTGCTCCCGGCTGTGGGCCATCTGGGGCAGGAAAGTGAGCCATT CCTAGGCTGAGGTCCAGGCAGCCCTGCCCCTGAAGACCCTCTAGGAGCAGGGCACCCAGTGGCCCTGCTGCTGTCCAGCCAGGCCTGCCT GAGGCCACGCTGCTATGGAGGCTGCCTCCTAGTCTCCCACCAGGTCCCAGGCTGTGGAAAGCCCCAGCCCAGGGATGGTCAGAACTCAGG GGCAGATTCCACTGCCCCTTCTGCCAAACACATCCAGAACCTGCCCTCAGCCCTGGAAGCTAGCATCTTCTGGGGCCAGGGGCTTGCTTC CTCGCTCCATAGCCCTCAACTGCCCAGGCGCTCCCACCAGCAGAACTGAGCCTGCCTCCTCCTCCCAGCCTGCCCCGCTGCCCAGAGGAC CCCACGCCTCTCAGAGGCAGAGGTCCCATGACAGCCTTTGACCCACAACGGCCACACAGCCGCCTCCAGACCAGCACTCGGACTGCCCTG CAGTGGCCGCTTGGGCCTCCCTGGCGGTCCCGCCCTGCCCTAGGCTTTACCTTGGAAGCCTGAGAGGCGCCGGCTCTCTTGCTCCTCCAT CGATGGACACTGCATTGCTTCTCATCGGACACTTGTGGAGCGCAGGGGCCTGGGGAGCAGCGCTAACCCTGGAGGCAGCCTTTGGGTGAT GGCTTTTTCTTCCCTTTTCCTCCCGCGGGCCTGTTTTCAGGTGTTCCTAGCATTTCTGCCTCCAGGCAGGACGGCAGGGGTGAGCAGCTT TGGGAGAGACACCTGGCCTTTTTCTCCTGGAGCCTCTCCCTCCCGGCCCTGGGAAGTGGGCGCAGCCCTGTGTTCCCCCAGCTTGGCAGA TGGGCTGCATGCGGCGCTCCCTTCCTTCCCACGCTCAGCGGCCCCGGCCAGACCCTGGCAGACTTCACACCTCATTGCTTTACCCCCTGG >14203_14203_2_CCNT2-ZER1_CCNT2_chr2_135677461_ENST00000295238_ZER1_chr9_131505024_ENST00000291900_length(amino acids)=393AA_BP=80 MASGRGASSRWFFTREQLENTPSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNVQRNCCLTLC NFSIPEELEFQYRRVNELLLSILNPTRQDESIQRIAVHLCNALVCQVDNDHKEAVGKMGFVVTMLKLIQKKLLDKTCDQVMEFSWSALWN ITDETPDNCEMFLNFNGMKLFLDCLKEFPEKQELHRNMLGLLGNVAEVKELRPQLMTSQFISVFSNLLESKADGIEVSYNACGVLSHIMF DGPEAWGVCEPQREEVEERMWAAIQSWDINSRRNINYRSFEPILRLLPQGISPVSQHWATWALYNLVSVYPDKYCPLLIKEGGMPLLRDI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CCNT2-ZER1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000264157 | + | 2 | 9 | 1_300 | 80.0 | 731.0 | MDFIC and MDFI |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000295238 | + | 2 | 10 | 1_300 | 80.0 | 664.0 | MDFIC and MDFI |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000264157 | + | 2 | 9 | 250_300 | 80.0 | 731.0 | POLR2A |
Hgene | CCNT2 | chr2:135677461 | chr9:131505024 | ENST00000295238 | + | 2 | 10 | 250_300 | 80.0 | 664.0 | POLR2A |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CCNT2-ZER1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CCNT2-ZER1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |